SGTX Past Earnings image   This SGTX past earnings page last updated 11/11/2022
SGTX Past Earnings
PeriodPast Earnings DateGAAP
Q3 202211/10/2022-0.270
Q2 20228/4/2022-0.440
Q1 20225/12/2022-0.430
Q4 20213/14/2022-0.550
Q3 202111/10/2021-0.630
Q2 20218/10/2021-0.650
Q1 20215/10/2021-0.600
Q4 20203/18/2021-1.150
SGTX Past Revenue
PeriodPast Earnings DateGAAP
Q3 202211/10/20220.00B
Q2 20228/4/20220.00B
Q1 20225/12/20220.00B
Q4 20213/14/20220.00B
Q3 202111/10/20210.00B
Q2 20218/10/20210.00B
Q1 20215/10/20210.00B
Q4 20203/18/20210.00B
Quotes delayed 20 minutes

Email EnvelopeFree SGTX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Sigilon Therapeutics (SGTX) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

SHC Past Earnings
SIBN Past Earnings
SIEN Past Earnings
SIGA Past Earnings
SILK Past Earnings
SINT Past Earnings
SIOX Past Earnings
SKIN Past Earnings
SLDB Past Earnings
SLNO Past Earnings

SGTX Past Earnings Q&A

What was the best and worst SGTX past earnings results?
For Sigilon Therapeutics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest SGTX past earnings result in our data set was -0.270/share posted in Q3 2022, while the lowest was in Q4 2020 when SGTX posted -1.150/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q3 2022 when SGTX reported 0.00B in revenue, while the quarter with the lowest revenue in our data set was Q3 2021 at 0.00B of revenue.

  Suggested answer: There are 8 SGTX past earnings results in our data set.

On this page we presented the SGTX past earnings date information for Sigilon Therapeutics. Reviewing that SGTX Past Earnings for the company, we see that the highest past earnings result in our data set was in Q3 2022, when SGTX posted gaap of -0.270/share. Meanwhile the lowest SGTX past earnings result was in Q4 2020, when SGTX posted gaap of -1.150/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q3 2022 when SGTX reported 0.00B in revenue, while the smallest revenue quarter was Q3 2021 when SGTX reported 0.00B in revenue.

Any self directed investor doing their due diligence on SGTX or any other given stock can benefit from researching all of the Sigilon Therapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Sigilon Therapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for SGTX. Thanks for visiting, and the next time you need to research SGTX past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: Top Ten Hedge Funds Holding CBEX, SRT market cap history, YPS Options Chain.

 

SGTX Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.